Reaction
Macular Fibrosis reporting signals
As of the last recalculation, Macular Fibrosis appears in 675 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 114.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranibizumab | 86 | 114.3 | 114.7 |
| Aflibercept | 51 | 54.4 | 54.5 |
| Ganciclovir | 13 | 39.9 | 40.0 |
| Ganciclovir Sodium | 13 | 38.6 | 38.6 |
| Brinzolamide | 7 | 25.1 | 25.1 |
| Prednisolone Acetate | 8 | 24.1 | 24.1 |
| Travoprost | 6 | 21.6 | 21.6 |
| Timolol | 7 | 18.0 | 18.1 |
| Bevacizumab | 53 | 14.2 | 14.2 |